Salivary Micro-RNA and Oral Squamous Cell Carcinoma: A Systematic Review.
biomarker
diagnosis
miRNAs
oral squamous cell carcinoma
prognosis
saliva
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
04 Feb 2021
04 Feb 2021
Historique:
received:
19
12
2020
revised:
29
01
2021
accepted:
01
02
2021
entrez:
9
2
2021
pubmed:
10
2
2021
medline:
10
2
2021
Statut:
epublish
Résumé
Oral squamous cell carcinoma (OSCC) is a widespread malignancy with high mortality. In particular, a delay in its diagnosis dramatically decreases the survival rate. The aim of this systematic review was to investigate and summarize clinical results in the literature, regarding the potential use of salivary microRNAs (miRNAs) as diagnostic and prognostic biomarkers for OSCC patients. Twelve papers were selected, including both case-control and cohort studies, and all of them detected significantly dysregulated miRNAs in OSCC patients compared to healthy controls. Based on our results, salivary miRNAs might provide a non-invasive and cost-effective method in the diagnosis of OSCC, and also to monitor more easily its evolution and therapeutic response and therefore aid in the establishment of specific therapeutic strategies.
Identifiants
pubmed: 33557138
pii: jpm11020101
doi: 10.3390/jpm11020101
pmc: PMC7913841
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Oral Oncol. 2016 Feb;53:42-7
pubmed: 26675284
Syst Rev. 2018 Oct 2;7(1):150
pubmed: 30285880
Int J Oncol. 2017 Nov;51(5):1541-1552
pubmed: 29048658
J Extracell Vesicles. 2014 Mar 26;3:
pubmed: 24683445
Expert Rev Mol Diagn. 2018 Jan;18(1):85-112
pubmed: 29134827
Int J Mol Sci. 2018 Jun 16;19(6):
pubmed: 29914173
Oral Oncol. 2019 Sep;96:113-120
pubmed: 31422202
Clin Exp Metastasis. 2019 Jun;36(3):291-302
pubmed: 30877500
Int J Mol Sci. 2020 Jul 27;21(15):
pubmed: 32727045
Head Neck. 2015 May;37(5):755-62
pubmed: 24596227
J Clin Med. 2019 Jun 21;8(6):
pubmed: 31234311
J Cancer. 2018 Jan 6;9(4):638-649
pubmed: 29556321
Exp Biol Med (Maywood). 2017 Mar;242(5):459-472
pubmed: 27903834
Oral Oncol. 2019 Dec;99:104465
pubmed: 31756680
J Dent Res. 2014 Jul;93(7 Suppl):86S-93S
pubmed: 24718111
Clin Cancer Res. 2009 Sep 1;15(17):5473-7
pubmed: 19706812
Int J Mol Sci. 2018 Jun 08;19(6):
pubmed: 29890622
Oral Dis. 2019 Jun;25 Suppl 1:79-87
pubmed: 31140691
EBioMedicine. 2018 Oct;36:209-220
pubmed: 30243489
Biomed Pharmacother. 2020 Jan;121:109553
pubmed: 31704611
Oncotarget. 2015 Mar 20;6(8):6062-75
pubmed: 25714028
Anal Chem. 2020 Oct 6;92(19):13336-13342
pubmed: 32809800
Braz Oral Res. 2020 Feb 10;34:e002
pubmed: 32049107
J Oral Pathol Med. 2019 Nov;48(10):871-879
pubmed: 31169322
PLoS One. 2011;6(11):e27840
pubmed: 22132151
J Oral Pathol Med. 2018 Nov;47(10):954-963
pubmed: 30244508
F1000Res. 2020 Apr 2;9:229
pubmed: 32399208
Head Neck. 2012 Feb;34(2):219-24
pubmed: 22083872
Ann N Y Acad Sci. 2012 Jul;1259:26-32
pubmed: 22758633
J Oral Pathol Med. 2021 Feb;50(2):123-128
pubmed: 33184963
Oncotarget. 2017 Jul 27;8(47):82459-82474
pubmed: 29137278
Oncol Rep. 2021 Jan;45(1):58-64
pubmed: 33200230
Biomed Res Int. 2018 Nov 21;2018:9792730
pubmed: 30584540
Int J Oral Maxillofac Surg. 2019 Sep;48(9):1131-1137
pubmed: 30878273
Front Physiol. 2019 Dec 10;10:1476
pubmed: 31920689
Am J Cancer Res. 2017 Apr 01;7(4):913-922
pubmed: 28469963
Oral Dis. 2015 Sep;21(6):739-47
pubmed: 25784212
Cell Oncol (Dordr). 2018 Jun;41(3):329-334
pubmed: 29480379
Br J Cancer. 2006 Mar 27;94(6):776-80
pubmed: 16495913
Cell Oncol (Dordr). 2014 Oct;37(5):331-8
pubmed: 25156495
J Craniomaxillofac Surg. 2016 Jul;44(7):876-81
pubmed: 27210505
Cancers (Basel). 2020 Apr 10;12(4):
pubmed: 32290144
Oral Oncol. 2017 Jul;70:23-28
pubmed: 28622887
Clin Cancer Res. 2004 Dec 15;10(24):8442-50
pubmed: 15623624
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Oncol Rep. 2017 Aug;38(2):1268-1275
pubmed: 28677748
Int J Mol Med. 2016 Nov;38(5):1359-1366
pubmed: 28025988
Adv Clin Chem. 2011;55:21-34
pubmed: 22126022
Cell Oncol (Dordr). 2016 Apr;39(2):187-93
pubmed: 26650483
Front Med. 2017 Dec;11(4):522-527
pubmed: 28744793
J Oral Pathol Med. 2018 Oct 19;:
pubmed: 30339289
Medicine (Baltimore). 2019 Mar;98(13):e14922
pubmed: 30921188
Theranostics. 2018 Jan 1;8(2):486-504
pubmed: 29290822
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Inflammopharmacology. 2017 May 13;:
pubmed: 28502067
Clin Cancer Res. 2008 Oct 1;14(19):6246-52
pubmed: 18829504
Cell Res. 2008 Oct;18(10):997-1006
pubmed: 18766170
PLoS One. 2020 Mar 24;15(3):e0221779
pubmed: 32208417
BMC Cancer. 2013 Mar 19;13:129
pubmed: 23510112
Oral Oncol. 2018 Aug;83:46-52
pubmed: 30098778
Oncotarget. 2017 Oct 10;8(59):99990-100001
pubmed: 29245955
Am J Cancer Res. 2016 Jul 01;6(7):1461-93
pubmed: 27508091
Oral Dis. 2015 Mar;21(2):195-206
pubmed: 24690080
J BUON. 2018 Jan-Feb;23(1):167-172
pubmed: 29552778
Arch Oral Biol. 2007 Jan;52(1):30-5
pubmed: 17052683
BMC Cancer. 2017 Nov 09;17(1):730
pubmed: 29121858
Methods Mol Biol. 2013;1024:183-90
pubmed: 23719951
Cancer Prev Res (Phila). 2018 Aug;11(8):491-502
pubmed: 29764807
Clin Oral Implants Res. 2017 Sep;28(9):e121-e134
pubmed: 27492799
Front Oncol. 2018 Oct 08;8:398
pubmed: 30349810
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S406-14
pubmed: 23138850
BMC Cancer. 2018 Apr 18;18(1):439
pubmed: 29669525
Annu Rev Pathol. 2014;9:287-314
pubmed: 24079833
Clin Lab. 2015;61(10):1373-81
pubmed: 26642697
Dis Markers. 2019 Nov 18;2019:8632018
pubmed: 31827646
Clin Lab. 2017 Nov 1;63(11):1771-1776
pubmed: 29226639
Clin Oral Investig. 2020 Nov;24(11):3833-3841
pubmed: 33009627